Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-24-004035

CVP, EMEACLA and JAPAC sold 14,400 shares at $91.68 ($1,320,149)

  • CVP, EMEACLA and JAPAC acquired 14,400 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lemercier Jean-Luc M · CVP, EMEACLA and JAPAC

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-03-11 Exercise or conversion : show line 1 in the form 10b5-1 +14,400 $36.75 $529,200 187,983.78 D
2024-03-11 Sale : show line 2 in the form 10b5-1 −14,400 $91.68 $1,320,149 173,583.78 D
Open-market sales · 14,400 sh · avg $91.68 · $1,320,149

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2024-03-11 Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) −14,400 $36.75 2024-05-10 14,400 28,800 D
Loading xslF345X05/doc4.xml…